Literature DB >> 15277626

Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling.

M A De Georgia1, D W Krieger, A Abou-Chebl, T G Devlin, M Jauss, S M Davis, W J Koroshetz, G Rordorf, S Warach.   

Abstract

OBJECTIVE: To report results of a randomized pilot clinical feasibility trial of endovascular cooling in patients with ischemic stroke.
METHODS: Forty patients with ischemic stroke presenting within 12 hours of symptom onset were enrolled in the study. An endovascular cooling device was inserted into the inferior vena cava of those randomized to hypothermia. A core body temperature of 33 degrees C was targeted for 24 hours. All patients underwent clinical assessment and MRI initially, at days 3 to 5 and days 30 to 37.
RESULTS: Eighteen patients were randomized to hypothermia and 22 to receive standard medical management. Thirteen patients reached target temperature in a mean of 77 +/- 44 minutes. Most tolerated hypothermia well. Clinical outcomes were similar in both groups. Mean diffusion-weighted imaging (DWI) lesion growth in the hypothermia group (n = 12) was 90.0 +/- 83.5% compared with 108.4 +/- 142.4% in the control group (n = 11) (NS). Mean DWI lesion growth in patients who cooled well (n = 8) was 72.9 +/- 95.2% (NS).
CONCLUSIONS: Induced moderate hypothermia is feasible using an endovascular cooling device in most patients with acute ischemic stroke. Further studies are needed to determine if hypothermia improves outcome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277626     DOI: 10.1212/01.wnl.0000129840.66938.75

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  106 in total

Review 1.  Therapeutic hypothermia for acute neurological injuries.

Authors:  Lucia Rivera-Lara; Jiaying Zhang; Susanne Muehlschlegel
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials?

Authors:  H Bart van der Worp; Malcolm R Macleod; Rainer Kollmar
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-31       Impact factor: 6.200

3.  Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results.

Authors:  Thomas M Hemmen; Rema Raman; Kama Z Guluma; Brett C Meyer; Joao A Gomes; Salvador Cruz-Flores; Christine A Wijman; Karen S Rapp; James C Grotta; Patrick D Lyden
Journal:  Stroke       Date:  2010-08-19       Impact factor: 7.914

4.  Therapeutic applications of hypothermia in cerebral ischaemia.

Authors:  Bruno P Meloni; Frank L Mastaglia; Neville W Knuckey
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

Review 5.  Medivance Arctic sun temperature management system.

Authors:  Romergryko G Geocadin; J Ricardo Carhuapoma
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

6.  Cooling blocks rat hippocampal neurotransmission by a presynaptic mechanism: observations using 2-photon microscopy.

Authors:  Xiao-Feng Yang; Yannan Ouyang; Bryan R Kennedy; Steven M Rothman
Journal:  J Physiol       Date:  2005-06-16       Impact factor: 5.182

Review 7.  Therapeutic temperature modulation in neurocritical care.

Authors:  Neeraj Badjatia
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

Review 8.  Hypothermia after acute ischemic stroke.

Authors:  Thomas M Hemmen; Patrick D Lyden
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

Review 9.  Therapeutic Hypothermia and Neuroprotection in Acute Neurological Disease.

Authors:  Kota Kurisu; Jong Youl Kim; Jesung You; Midori A Yenari
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

10.  Body Temperature Modulates Infarction Growth following Endovascular Reperfusion.

Authors:  S Dehkharghani; M Bowen; D C Haussen; T Gleason; A Prater; Q Cai; J Kang; R G Nogueira
Journal:  AJNR Am J Neuroradiol       Date:  2016-10-06       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.